News

President Trump recently announced an executive order to initiate the Genesis Mission, a federal initiative under the Department of Energy, aimed at accelerating the development of artificial

An analyst's price target increase for UnitedHealth Group (NYSE: UNH) stock was taken to heart by investors on Wednesday. Following news of the boost, they collectively pushed the large health insur

For years, UnitedHealth Group (NYSE: UNH) has been one of the best growth stocks to own on the New York Stock Exchange. A leading health insurance company, it generated solid and continuous growth

In this video, I will talk about the recent updates regarding Advanced Micro Devices (NASDAQ: AMD) and why I remain bullish on the name. Watch the short video to learn more, consider subscribing

Sometimes, everything can seem to be going your way. And then the wheels fall off. That's the situation Summit Therapeutics (NASDAQ: SMMT) finds itself in.

Shares of the clinical-stage biotech

UnitedHealth (NYSE: UNH) stock is testing the patience of investors.

*Stock prices used were the afternoon prices of Nov. 28, 2025. The video was published on Nov. 30, 2025.

Continue reading

Source

Appaloosa Management's founder, David Tepper, has long been known for his impressive and consistent returns on Wall Street. The billionaire investor and prominent hedge fund manager has built a name

New investing trends pop up on Wall Street all the time. Over the past seven years, we have witnessed excitement surrounding cannabis stocks, the metaverse, artificial intelligence, and more

It's not possible to go back in time and invest in Nvidia or Amazon when they were still relatively small companies. However, it is possible to identify corporations that appear poised to establish

The U.S. healthcare industry has been a lightning rod for controversy for years, but it's especially murky right now.

A political battle continues within the U.S. government over renewing expired

Earnings season always creates short-term winners and losers. Beverage behemoth Coca-Cola (NYSE: KO) and biotech giant Amgen (NASDAQ: AMGN) were firmly in the former category, as both delivered

Axsome Therapeutics (NASDAQ: AXSM) and Exelixis (NASDAQ: EXEL) are hardly the best-known players in the large biotech industry. Thankfully, they don't need to be so to have excellent prospects. Both

It seems the artificial intelligence (AI) race has escalated once again following President Donald Trump's announcement that he has issued an executive order to launch Project Genesis. The

Recent developments have led to significant declines in the stock prices of Pinterest (NYSE: PINS) and Zoetis (NYSE: ZTS). Due to company-specific issues, both are currently not that far from their

Shares of Regeneron Pharmaceuticals (NASDAQ: REGN), a biotech giant, have been southbound over the past two years as the company navigates challenges to one of its main growth drivers, Eylea. This

Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY) are two of the largest and most respected pharmaceutical companies in the world. If you are looking to buy high-quality companies, they should

Semiconductor stocks like Nvidia, Broadcom, and Advanced Micro Devices have produced tremendous long-term returns due to their artificial intelligence (AI) chips.

While semiconductors are the early

Healthcare has been a painful industry to invest in this year. Rising claims usage and overall medical costs have sent expenses soaring for insurers such as UnitedHealth Group, whose stock is now

Shares of the pharmaceutical giant Pfizer (NYSE: PFE) have suffered over the last three years, falling some 50% since December 2022. Shares have been weighed down by the collapse in revenue from its

While few investors have successfully timed the markets, buy-and-hold strategies tend to yield favorable results over the long term. The key is to select well-run companies that make highly

Abbott Laboratories (NYSE: ABT), a medical device specialist, has a lot going its way. The company has a large and diversified portfolio of products, which it routinely expands through new launches

Over the past 18 months, Merck (NYSE: MRK) shares have been mostly southbound as the drugmaker encountered several headwinds. Its vaccine business isn't performing as well as expected, resulting in

Sven Wehrwein, a member of the Board of Directors at AtriCure (NASDAQ:ATRC), exercised 10,000 non-qualified stock options and immediately sold the underlying shares in derivative transactions on

Want some quality income-generating investments you can put in your portfolio for the long term, and not worry about? The stocks listed below check off those boxes and can make for ideal investments